What is the proper protocol for administering a Glyceryl Trinitrate (GTN) infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Protocol for Administering Glyceryl Trinitrate (GTN) Infusion

Intravenous GTN should be initiated at 10 mcg/min through continuous infusion via non-absorbing tubing and titrated upward by 10 mcg/min every 3-5 minutes until symptom relief or blood pressure response is achieved, with a typical ceiling dose of 200 mcg/min. 1

Preparation and Administration

Initial Setup

  • Use non-absorbing tubing (though studies show standard polyvinyl chloride tubing can be effective) 2
  • Ensure central venous access is established (superior or inferior vena cava placement is ideal) 1
  • Prepare GTN solution according to institutional protocol (typically 50mg in 250mL or 100mg in 500mL)

Dosing Protocol

  1. Starting dose: 10 mcg/min 1
  2. Titration: Increase by 10 mcg/min every 3-5 minutes 1
  3. Dose adjustment:
    • If no response at 20 mcg/min, increase by 10-20 mcg/min increments 1
    • Continue titration until either:
      • Relief of symptoms (e.g., chest pain, pulmonary congestion)
      • Blood pressure response achieved
      • Maximum dose reached
  4. Maximum dose: Typically 200 mcg/min (though prolonged infusion at 300-400 mcg/min has been used safely) 1

Monitoring Parameters

  • Blood pressure: Monitor continuously during titration
  • Heart rate: Watch for reflex tachycardia
  • Symptoms: Assess for relief of chest pain or pulmonary congestion
  • ECG: Monitor for ischemic changes

Clinical Endpoints

  • Primary endpoint: Relief of symptoms (e.g., chest pain, pulmonary congestion)
  • Secondary endpoint: Blood pressure response
    • If symptoms are relieved, no need to continue increasing dose to effect blood pressure response 1
    • If symptoms persist, increase dose until blood pressure response is observed 1

Special Considerations

Contraindications

  • Hypotension (systolic BP <90 mmHg or 30 mmHg below baseline) 3
  • Use of phosphodiesterase inhibitors:
    • Sildenafil within previous 24 hours
    • Tadalafil within previous 48 hours
    • Vardenafil (timing not established, but at least 24 hours) 1
  • Right ventricular infarction 3
  • Severe aortic stenosis 3

Important Precautions

  • Cannula selection: Smaller cannulas (e.g., pink) may deliver medication faster than larger ones at low infusion rates 4
  • Nitrate tolerance: Develops within 24 hours of continuous administration 1
  • Abrupt cessation: Can exacerbate ischemic changes on ECG; use gradual dose reduction when discontinuing 1
  • Transition to oral nitrates: Consider oral isosorbide dinitrate when transitioning from IV GTN to prevent rebound phenomena 5

Discontinuation Protocol

  1. When to discontinue: After 16-24 hours (due to tolerance development) 1
  2. How to discontinue: Gradually reduce the dose rather than abrupt cessation 1
  3. Transition to oral nitrates: Consider oral isosorbide dinitrate (10 mg three times daily) when transitioning from IV GTN 5

Complications and Management

  • Hypotension: Reduce dose or temporarily discontinue infusion
  • Headache: Common side effect; may require symptomatic treatment
  • Reflex tachycardia: Monitor heart rate; consider beta-blockers if problematic 3
  • Methemoglobinemia: Rare with standard doses; monitor for cyanosis unresponsive to oxygen

Practical Tips

  • For acute pulmonary edema, the European Society of Cardiology recommends GTN at doses of 20-200 mcg/min, carefully titrated against blood pressure 1
  • The maximum hemodynamic effect of GTN typically occurs around 20 minutes after starting administration 6
  • Ensure proper drug delivery by using appropriate infusion rates, especially with larger cannulas 4

By following this protocol, you can safely and effectively administer GTN infusions to patients requiring vasodilation for conditions such as acute coronary syndromes or acute heart failure.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Refractory Chest Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.